1 Risky ETF You Want to Avoid Buying in December

Vanguard Information Technology ETF (VGT) has risen nearly 21% year-to-date through November but is highly concentrated: 314-stock ETF is market-cap weighted and its top three holdings—Nvidia (18.18%, $4.366T market cap), Apple (14.29%, $4.144T), and Microsoft (12.93%, $3.63T)—account for over 45% of the fund. The author cautions against buying VGT in December due to this megacap concentration and rising market uncertainty, noting that less concentrated alternatives like QQQ carry roughly a quarter weight in those names while delivering similar YTD performance.

Analysis

Market structure: The market is bifurcating into a narrow megacap-led tech market (NVDA 18%, AAPL 14%, MSFT 13% weight inside VGT) and a broad rest-of-tech cohort. That concentration amplifies idiosyncratic moves in NVDA/MSFT/AAPL into ETF flows and index performance; expect index-tracking flows to keep bid under these names near-term while mid/micro-cap tech lags. Cross-asset: risk-on into megacaps tends to push 2s10s wider, raise equity-implied vols for NVDA, and strengthen USD via tech-sector dollar demand; expect higher copper/energy intensity from AI capex over 12–36 months.

Risk assessment: Tail risks include regulatory/antitrust action against cloud/AI monopolies, a semiconductor supply shock (TSMC/ASML capex disruption), or a rapid mean-reversion in AI sentiment — each could wipe 20–40% off concentrated holdings in 1–3 months. Immediate (days) risk is dispersion/volatility into December rebalancing; short-term (weeks) is index reweighting and options gamma squeezes; long-term (years) hinge on AI TAM delivery vs. lofty multiples. Hidden dependencies: ETF creation/redemption mechanics, concentrated options open interest, and prime-broker margining can create non-linear liquidity shocks.

Trade implications: Prefer targeted exposure to AI hardware and supply chain rather than broad cap-weighted VGT. Use long-dated NVDA exposure for asymmetric upside and sell short-dated VGT downside protection to hedge index concentration. Rotate 2–5% allocation from cap-weighted tech ETFs into semiconductor-equipment (ASML, LRCX) and diversified QQQ to lower single-stock beta.

Contrarian angles: Consensus to avoid VGT may be overstated — concentration has historically outperformed during paradigm shifts; underweighting risks missing structural winners if NVDA/MSFT/AAPL continue to compound earnings. A tactical countertrade is selling VGT tail-protection while buying QQQ/ASML exposure because the market may leave pricing inefficiencies in midcap tech. Watch for unintended liquidity squeezes during December rebalances that could create transient but tradable dislocations.

Key Decisions for Investors

• Establish a tactical 2% net-long position in NVDA via Jan 2026 LEAP calls (buy NVDA Jan 2026 $450 calls or equivalent delta ~0.60) sized so max premium risk = 2% portfolio; set hard stop to exit or hedge if NVDA spot drops >25% from entry or if implied vol collapses >30% in 30 days.
• Reduce passive exposure to VGT by 3–5% of portfolio and redeploy into QQQ (ticker QQQ) and ASML (ticker ASML): target a 2% QQQ overweight and 1–3% ASML position to lower single-stock concentration while preserving tech upside over 6–18 months.
• Sell 4–6 week out-of-the-money (OTM) put spreads on MSFT (ticker MSFT) to collect premium while setting entry if weakness arrives: sell the 2–3% OTM put and buy 6–8% OTM put as a defined-risk income trade, rolling only on sustained volatility contraction below 50% of current IV within 30 days.
• If holding VGT, buy a 3% notional protective put (VGT 1–2 month OTM) or cap position size: exit or hedge if VGT falls >15% from current levels or if NVDA/AAPL/MSFT report a combined sequential EPS miss across their next two earnings windows (monitor next 30–60 days).